Market Whales and Their Recent Bets on NVAX Options
Market Whales and Their Recent Bets on NVAX Options
Investors with a lot of money to spend have taken a bearish stance on Novavax (NASDAQ:NVAX).
擁有足夠資金的投資者對諾瓦瓦克斯醫藥（納斯達克：NVAX）持看淡態度。
And retail traders should know.
零售交易者應該知道。
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
我們在這裏追蹤的公開期權歷史記錄上看到交易時發現了這一點。
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NVAX, it often means somebody knows something is about to happen.
不管這些是機構還是富人，我們不知道。但是當發生這樣大的事情，通常意味着有人知道即將發生的事情。
So how do we know what these investors just did?
那麼我們如何知道這些投資者剛剛做了什麼呢？
Today, Benzinga's options scanner spotted 9 uncommon options trades for Novavax.
今天，Benzinga的期權掃描器發現了9筆罕見的諾瓦瓦克斯醫藥期權交易。
This isn't normal.
這不正常。
The overall sentiment of these big-money traders is split between 33% bullish and 55%, bearish.
這些大手交易者的總體情緒分爲33%的看好和55%的看淡。
Out of all of the special options we uncovered, 4 are puts, for a total amount of $527,518, and 5 are calls, for a total amount of $169,538.
在我們發現的所有特殊期權交易中，共有4個看跌期權，總金額爲527,518美元，5個看漲期權，總金額爲169,538美元。
What's The Price Target?
目標價是多少？
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $12.5 and $30.0 for Novavax, spanning the last three months.
經過對成交量和未平倉量的評估，可以看出市場主力正專注於12.5美元至30美元的價格區間，覆蓋過去三個月的諾瓦瓦克斯醫藥股票。
Volume & Open Interest Trends
成交量和未平倉量趨勢
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
這些數據可以幫助您跟蹤Coinbase Glb期權的流動性和利益，以給定的行權價格爲基礎。
This data can help you track the liquidity and interest for Novavax's options for a given strike price.
這些數據可以幫助您跟蹤特定執行價格的諾瓦瓦克斯醫藥期權的流動性和興趣。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novavax's whale activity within a strike price range from $12.5 to $30.0 in the last 30 days.
下面，我們可以觀察到涵蓋12.5美元至30美元行權價格範圍內所有諾瓦瓦克斯醫藥鯨魚活動的看漲和看跌數量發展趨勢，對應於過去30天中的成交量和未平倉量。
Novavax Option Activity Analysis: Last 30 Days
諾瓦瓦克斯醫藥期權活動分析：過去30天
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | PUT | SWEEP | BEARISH | 01/16/26 | $3.3 | $2.98 | $3.3 | $12.50 | $261.6K | 12.7K | 1.2K |
| NVAX | PUT | SWEEP | BEARISH | 01/16/26 | $3.35 | $3.3 | $3.3 | $12.50 | $160.7K | 12.7K | 489 |
| NVAX | PUT | TRADE | BULLISH | 01/17/25 | $6.65 | $6.35 | $6.38 | $20.00 | $54.8K | 551 | 103 |
| NVAX | PUT | TRADE | BULLISH | 01/17/25 | $10.25 | $9.95 | $10.05 | $25.00 | $50.2K | 85 | 50 |
| NVAX | CALL | TRADE | BEARISH | 01/16/26 | $4.4 | $4.3 | $4.3 | $30.00 | $49.0K | 1.7K | 168 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | 看跌 | SWEEP | 看淡 | 01/16/26 | $3.3 | $2.98 | $3.3 | 該公司股價收盤價爲10.54美元。 | $261.6K | 12.7K | 1.2K |
| NVAX | 看跌 | SWEEP | 看淡 | 01/16/26 | $3.35 | $3.3 | $3.3 | 該公司股價收盤價爲10.54美元。 | $160.7K | 12.7K | 489 |
| NVAX | 看跌 | 交易 | 看好 | 01/17/25 | $6.65 | $ 6.35 | $6.38 | $20.00 | $54.8K | 551 | 103 |
| NVAX | 看跌 | 交易 | 看好 | 01/17/25 | $10.25 | $9.95 | $10.05 | $25.00 | $50.2K | 85 | 50 |
| NVAX | 看漲 | 交易 | 看淡 | 01/16/26 | $4.4 | $4.3 | $4.3 | $30.00 | $49.0千 | 1.7K | 168 |
About Novavax
關於諾瓦瓦克斯
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
諾瓦瓦克斯公司是一家開發疫苗的生物技術公司。該公司在開發的臨床階段致力於推出預防廣泛疾病的新產品。諾瓦瓦克斯與其全資擁有的瑞典子公司合作，生產能夠應對已知和新出現的疾病威脅的疫苗候選品。該公司認爲其疫苗技術具有廣泛應用於多種人類傳染性疾病的潛力。該公司將其業務管理爲一個經營部門，即疫苗的研發和商業化。該公司從歐洲獲取最大收入。
Present Market Standing of Novavax
諾瓦瓦克斯醫藥的現行市場狀況
- Trading volume stands at 5,964,568, with NVAX's price up by 2.94%, positioned at $17.16.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 11 days.
- 交易量爲5,964,568股，NVAX的價格上漲了2.94％，目前爲17.16美元。
- RSI指標顯示該股票可能接近超買。
- 預計在11天內公佈收益報告。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Novavax with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險，但也提供了更高的利潤潛力。精明的交易者通過不斷的教育、策略性的交易調整、利用各種因子和保持對市場動態的敏感來降低這些風險。使用Benzinga Pro即時警報了解諾瓦瓦克斯醫藥的最新期權交易。
譯文內容由第三人軟體翻譯。